Dalton, Greiner, Hartman, Maher & Co’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-26,979
| Closed | -$1.78M | – | 181 |
|
|
2016
Q3 | $1.78M | Buy |
26,979
+525
| +2% | +$34.7K | 0.12% | 126 |
|
|
2016
Q2 | $1.5M | Sell |
26,454
-15,947
| -38% | -$904K | 0.09% | 133 |
|
|
2016
Q1 | $2.47M | Buy |
42,401
+5,192
| +14% | +$303K | 0.15% | 104 |
|
|
2015
Q4 | $2.19M | Buy |
37,209
+7,904
| +27% | +$465K | 0.13% | 108 |
|
|
2015
Q3 | $1.68M | Sell |
29,305
-91
| -0.3% | -$5.2K | 0.09% | 119 |
|
|
2015
Q2 | $2.65M | Buy |
29,396
+394
| +1% | +$35.6K | 0.14% | 106 |
|
|
2015
Q1 | $2.79M | Sell |
29,002
-340
| -1% | -$32.7K | 0.16% | 103 |
|
|
2014
Q4 | $2.57M | Buy |
29,342
+5,810
| +25% | +$509K | 0.14% | 104 |
|
|
2014
Q3 | $2.15M | Buy |
23,532
+3,506
| +18% | +$320K | 0.12% | 109 |
|
|
2014
Q2 | $2.31M | Sell |
20,026
-107
| -0.5% | -$12.3K | 0.12% | 103 |
|
|
2014
Q1 | $2.44M | Sell |
20,133
-952
| -5% | -$115K | 0.14% | 102 |
|
|
2013
Q4 | $2.65M | Sell |
21,085
-5,849
| -22% | -$735K | 0.15% | 101 |
|
|
2013
Q3 | $2.93M | Sell |
26,934
-2,086
| -7% | -$227K | 0.2% | 103 |
|
|
2013
Q2 | $2.45M | Buy |
+29,020
| New | +$2.45M | 0.19% | 104 |
|